Halstead Michael's Form 4 filing
Intra-Cellular Therapies, Inc. (ITCI) · filed Mar 11, 2024
- Accession no.
- 0000950170-24-029581
- Filed
- Mar 11, 2024
- Trade date
- Mar 7-11, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $1.35M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Halstead MichaelCIK 0001521548 | Officer (EVP and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 7, 2024 | Common Stock | SSaleDisposed | −12,912 | $66.14 | −$853,999.68 | 220 | Direct | |
| Mar 7, 2024 | Common Stock | SSaleDisposed | −220 | $66.81 | −$14,698.2 | 0 | Direct | |
| Mar 10, 2024 | Common Stock | MOption exerciseAcquired | +7,345 | – | – | 7,345 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −6,107 | $65.82 | −$401,962.74 | 1,238 | Direct | |
| Mar 11, 2024 | Common Stock | SSaleDisposed | −1,238 | $66.70 | −$82,574.6 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 10, 2024 | Common Stock | MOption exerciseDisposed | −7,345 | $0.00 | $0 | 7,345 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.